In addition to the classical nuclear receptor for estrogen, a G-protein coupled receptor, GPR30 was identified in the ER-positive breast cancer cell line MCF-7 in 1997 (Tskitishvili et al., 2017), also known as G protein coupled estrogen receptor (GPER). Here, GPER1 is linked to breast carcinoma.